Search Results 1-10 of 27414 for ������������KA���:ZA31���24������ ���������������������������������
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
unexplained cough for which an underlying condition has not been determined despite adequate investigation with diagnostic tests and trials of therapy.
This study is being conducted to examine survival, safety, and the magnitude of the immune response induced following administration of DN24-02 in subjects with ...
The purpose of this study is to evaluate the safety and tolerability of ART24 after 7 or 28 days of daily administration in recently-cured C. diff infection ...
"The CYP24A1 gene, encoding the vitamin D 24-hydroxylase, is of major clinical and physiologic importance because it also serves to regulate the catabolism of 1 ...
Incidence not known · Blurred vision · chest pain, discomfort, or tightness · confusion · cough · difficulty breathing · difficulty swallowing · dizziness, faintness, ...
Patients in Arm B will receive atezolizumab alone (until disease progression), and patients in Arm C will receive sunitinib 50 mg orally daily for 4 weeks ...
First, by comparison to simultaneously recorded video-EEG in the epilepsy monitoring unit (gold standard). Second, by comparison to self-reported seizure log ...
The Nicotine Dependence Center's eight-day residential treatment program is staffed 24 hours a day ... 24/7 support. Your gift holds great power – donate today ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.